These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 23334525)
1. Differentiation between idiopathic and atypical parkinsonian syndromes using three-dimensional magnetic resonance spectroscopic imaging. Gröger A; Bender B; Wurster I; Chadzynski GL; Klose U; Berg D J Neurol Neurosurg Psychiatry; 2013 Jun; 84(6):644-9. PubMed ID: 23334525 [TBL] [Abstract][Full Text] [Related]
2. Imaging the Nigrosome 1 in the substantia nigra using susceptibility weighted imaging and quantitative susceptibility mapping: An application to Parkinson's disease. Cheng Z; He N; Huang P; Li Y; Tang R; Sethi SK; Ghassaban K; Yerramsetty KK; Palutla VK; Chen S; Yan F; Haacke EM Neuroimage Clin; 2020; 25():102103. PubMed ID: 31869769 [TBL] [Abstract][Full Text] [Related]
3. The contribution of cerebellar proton magnetic resonance spectroscopy in the differential diagnosis among parkinsonian syndromes. Zanigni S; Testa C; Calandra-Buonaura G; Sambati L; Guarino M; Gabellini A; Evangelisti S; Cortelli P; Lodi R; Tonon C Parkinsonism Relat Disord; 2015 Aug; 21(8):929-37. PubMed ID: 26077167 [TBL] [Abstract][Full Text] [Related]
4. Multiparametric MR imaging of Parkinsonisms at 3 tesla: Its role in the differentiation of idiopathic Parkinson's disease versus atypical Parkinsonian disorders. Calloni SF; Conte G; Sbaraini S; Cilia R; Contarino VE; Avignone S; Sacilotto G; Pezzoli G; Triulzi FM; Scola E Eur J Radiol; 2018 Dec; 109():95-100. PubMed ID: 30527319 [TBL] [Abstract][Full Text] [Related]
5. Transcranial sonography for the discrimination of idiopathic Parkinson's disease from the atypical parkinsonian syndromes. Bouwmans AE; Vlaar AM; Srulijes K; Mess WH; Weber WE Int Rev Neurobiol; 2010; 90():121-46. PubMed ID: 20692498 [TBL] [Abstract][Full Text] [Related]
7. Three-dimensional magnetic resonance spectroscopic imaging in the substantia nigra of healthy controls and patients with Parkinson's disease. Gröger A; Chadzynski G; Godau J; Berg D; Klose U Eur Radiol; 2011 Sep; 21(9):1962-9. PubMed ID: 21484351 [TBL] [Abstract][Full Text] [Related]
8. Brainstem 1H-MR spectroscopy in patients with Parkinson's disease with REM sleep behavior disorder and IPD patients without dream enactment behavior. Hanoglu L; Ozer F; Meral H; Dincer A Clin Neurol Neurosurg; 2006 Feb; 108(2):129-34. PubMed ID: 15936138 [TBL] [Abstract][Full Text] [Related]
9. Usefulness of proton magnetic resonance spectroscopy in differentiating parkinsonian syndromes. Federico F; Simone IL; Lucivero V; Mezzapesa DM; de Mari M; Lamberti P; Petruzzellis M; Ferrari E Ital J Neurol Sci; 1999 Aug; 20(4):223-9. PubMed ID: 10551908 [TBL] [Abstract][Full Text] [Related]
10. Transcranial duplex in the differential diagnosis of parkinsonian syndromes: a systematic review. Vlaar AM; Bouwmans A; Mess WH; Tromp SC; Weber WE J Neurol; 2009 Apr; 256(4):530-8. PubMed ID: 19224315 [TBL] [Abstract][Full Text] [Related]
11. Differentiation of Parkinson's disease and atypical parkinsonian syndromes by transcranial ultrasound. Behnke S; Berg D; Naumann M; Becker G J Neurol Neurosurg Psychiatry; 2005 Mar; 76(3):423-5. PubMed ID: 15716540 [TBL] [Abstract][Full Text] [Related]
14. Inversion recovery MRI in idiopathic Parkinson disease is a very sensitive tool to assess neurodegeneration in the substantia nigra: preliminary investigation. Raff U; Hutchinson M; Rojas GM; Huete I Acad Radiol; 2006 Jun; 13(6):721-7. PubMed ID: 16679274 [TBL] [Abstract][Full Text] [Related]
15. The predictive value of transcranial duplex sonography for the clinical diagnosis in undiagnosed parkinsonian syndromes: comparison with SPECT scans. Vlaar AM; de Nijs T; van Kroonenburgh MJ; Mess WH; Winogrodzka A; Tromp SC; Weber WE BMC Neurol; 2008 Nov; 8():42. PubMed ID: 18992168 [TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance spectroscopy in Parkinson's disease and parkinsonian syndromes. Rango M; Arighi A; Biondetti P; Barberis B; Bonifati C; Blandini F; Pacchetti C; Martignoni E; Bresolin N; Nappi G Funct Neurol; 2007; 22(2):75-9. PubMed ID: 17637209 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Braak staging of brain pathology with Cao H; Shi J; Cao B; Kang B; Zhang M; Qu Q Neurosci Lett; 2017 Nov; 660():57-62. PubMed ID: 28844732 [TBL] [Abstract][Full Text] [Related]
18. The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study. Gaenslen A; Unmuth B; Godau J; Liepelt I; Di Santo A; Schweitzer KJ; Gasser T; Machulla HJ; Reimold M; Marek K; Berg D Lancet Neurol; 2008 May; 7(5):417-24. PubMed ID: 18394965 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of 123I-ioflupane and 123I-iodobenzamide SPECT scans in 248 patients with parkinsonian syndromes. Vlaar AM; de Nijs T; Kessels AG; Vreeling FW; Winogrodzka A; Mess WH; Tromp SC; van Kroonenburgh MJ; Weber WE Eur Neurol; 2008; 59(5):258-66. PubMed ID: 18264015 [TBL] [Abstract][Full Text] [Related]
20. Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes? Lannuzel A; Höglinger GU; Verhaeghe S; Gire L; Belson S; Escobar-Khondiker M; Poullain P; Oertel WH; Hirsch EC; Dubois B; Ruberg M Brain; 2007 Mar; 130(Pt 3):816-27. PubMed ID: 17303592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]